BioSpace News Archive

Data from pivotal trial of avasopasem manganese for the reduction of severe oral mucositis in patients with head and neck cancer intended to support New Drug Application

Faculty, programs will expand in neuroengineering, synthetic biology, physical biology

Quark Venture Inc. has petitioned the British Columbia Supreme Court to overturn an unfavourable arbitration award concerning its decision to deny further investment to MSI Methylation Sciences, Inc. (“MSI”).

Higher dose met primary endpoint, the Overall Neuropathy Limitation Scale (ONLS), with statistical significance (p = 0.008)

Hitachi, Ltd. announced today that its heavy ion beam therapy system(1) has started treatment at Osaka Heavy Ion Therapy Center as of October 16. This marks the first operation of Hitachi’s first heavy ion therapy system.

Amphion Innovations plc announces that the Company has agreed terms for re-structuring the loan payments under the Facility and the draw-down of an additional US $1.1 million (net after fees and expenses) under the loan facility as announced on 5 June 2014 (the “Facility”).

Two studies are part of broader effort to take aim at one of the world’s deadliest infections

Myriad Genetics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved BRACAnalysis CDx® to be used by healthcare professionals to identify patients with HER2-negative metastatic breast cancer (mBC) who have a germline BRCA mutation and are eligible for treatment with Pfizer’s PARP (poly ADP ribose polymerase) inhibitor, TALZENNA® (talazoparib).

Company announces patented blood-based diagnostic test expanding to other autoimmune diseases as well as cancer

DeltaTrak® will be highlighting its new FlashTrak PreCool Prime at PMA Fresh Summit, Booth 1562, on Oct. 19-20, 2018, at the Orange County Convention Center, Orlando, Florida.